FDA approves initiation of STEMI DTU pivotal randomized controlled trial

Image: The STEMI DTU safety and feasibility trial demonstrates the potential to reduce infarct size in STEMI. Photo: Courtesy of BUSINESS WIRE.



Related Article
Recommended Whitepaper

View More